Akeso Eulerpool Nyheter

Akeso Aktiens nyheter

Akeso bevakas av många journalister och investerare över hela världen. De senaste Akeso nyheterna samlar vi här.

• 9 maj ·

  SeekingAlpha
  Biotech Outperformance - Can't Take What's Already Earned
• 8 maj ·

  SeekingAlpha
  BeiGene, Ltd., Soon To Be BeOne Medicines: New Name And New Profit
• 2 maj ·

  Yahoo
  Summit Therapeutics Q1 Loss Narrower Than Expected, Sales Nil
• 26 april ·

  SeekingAlpha
  Summit Therapeutics: New Ivonescimab Data Raise Concerns
• 20 april ·

  SeekingAlpha
  Bullish On Akeso's Ivonescimab, But Valuation And Geopolitical Risks Remain
• 21 februari ·

  Yahoo
  Akeso Enrolled First Patient in The Phase III Clinical Trial of Ivonescimab in Combination with Chemotherapy for First-Line Treatment of Triple-Negative Breast Cancer
• 19 februari ·

  Yahoo
  Top Growth Companies With Insider Ownership In February 2025
• 6 februari ·

  Yahoo
  Akeso Announces the Completion of Patient Enrollment in the Phase III Clinical Trial (HARMONi-6) Comparing Ivonescimab and Tislelizumab for First-Line Treatment of Sq-NSCLC
• 17 januari ·

  Yahoo
  Insider-Favored Growth Stocks To Watch In January 2025
• 7 januari ·

  Yahoo
  Akeso to Share Global Strategy for New Drug Development at the 43rd J.P. Morgan Healthcare Conference